Oncoscience | A Case for Routine Evaluation of HER2 Expression in Ductal Carcinoma In Situ
February 17, 2023
PRESS RELEASE: On January 30, 2023, Oncoscience published a new editorial paper: “HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment!” continue reading »